Vinci Pharmaceuticals
Avon By The Sea, US · Founded 2019 · Delaware corporation
Founders & leadership
PG
Philip GioiaExecutive
Board
SK
Sigurd KirkBoard director
NA
Neil Austrian Jr.Board director
SH
Sarah HassanBoard director
RL
Richard LindstromBoard director
Reported raises · per SEC filings
Form D private placements$21.2M disclosed across 2 rounds · 2019–2026
▶$20.2MraisedJan 2026 · 53 investors · Other Health CareRule 506(b)
▶$20.2MraisedJan 2026 · 53 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sarah HassanDirector
- Richard LindstromDirector
- Sigurd KirkDirector
- Neil Austrian Jr.Director
- Philip GioiaExecutive Officer, Director
- Offering amount
- $25.3M
- Amount sold
- $20.2M
- Sales commissions
- $117.2K
- Placement agents
- THIRD SEVEN CAPITAL, LLC, SUPERVISION PARTNERS LLC
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedAug 2019 · 1 investors · Other Health CareRule 506(b)
▶$1MraisedAug 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Philip GioiaExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Vinci Pharmaceuticals raised?
- Vinci Pharmaceuticals has disclosed $21.2M raised across 2 rounds.
- Where is Vinci Pharmaceuticals headquartered?
- Vinci Pharmaceuticals is headquartered in Avon By The Sea, US.